Twelve years after the first transcatheter aortic valve implantation (TAVI) for severe aortic
stenosis (AS), European and American guidelines, as well as the FDA, indicated that TAVI is …

For decades, surgical aortic valve replacement (SAVR) has been the standard treatment for
severe aortic stenosis (AS). With the clinical introduction of the concept of transcatheter …

The introduction of transcatheter aortic valve implantation (TAVI) has revolutionised the
treatment of patients with symptomatic severe aortic valve stenosis (AS). In extreme and high …

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe
aortic stenosis (AS) over the last decade. The results of the Placement of Aortic …

The introduction of percutaneous treatment of severe aortic stenosis with transcatheter aortic
valve implantation (TAVI) remains one of the greatest achievements of interventional …

Aims: Although transcatheter aortic valve implantation (TAVI) is officially indicated for severe
aortic stenosis (AS) patients at intermediate or higher surgical risk, the procedure is now …

In the last decade, transcatheter aortic valve implantation (TAVI), a disruptive technology,
has revolutionized the therapy of symptomatic severe aortic stenosis, and current guidelines …

With a rapidly aging society, the number of patients with cardiovascular disease—in
particular aortic stenosis—is progressively increasing. Although conventional aortic valve …

Aims: The indication for transcatheter aortic valve implantation (TAVI) has evolved from
inoperable patients to patients at increased surgical risk. In low-risk patients, surgical aortic …

Background Transcatheter aortic valve replacement (TAVR) has been approved for use in
patients with severe aortic stenosis at intermediate, high and extreme surgical risk. This …